Self-deleting retrovirus vectors for gene therapy

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 4927-4932

  Russ, Andreas P ^a   Friedel, Christina ^a   Grez, Manuel ^a,b   Von Melchner, Harald ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ARTICLE; GENE INSERTION; GENE SEQUENCE; GENE THERAPY; GENETIC TRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENE;

EID: 0030011519     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.4927-4932.1996     Document Type: Article

References (48)

1. Adra, C. N., P. H. Boer, and M. W. McBurney. 1987. Cloning and expression of the mouse pgk-1 gene and nucleotide sequence of its promoter. Gene 60:65-74.
2. Akgün, E., M. Ziegler, and M. Grez. 1991. Determinant of retrovirus gene expression in embryonal carcinoma cells. J. Virol. 65:382-388.
3. Araki, K., M. Araki, J. Miyazaki, and P. Vassalli. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc. Natl. Acad. Sci. USA 92:160-164.
4. Baubonis, W., and B. Sauer. 1993. Genomic targeting with purified Cre recombinase. Nucleic Acids Res. 21:2025-2029.
5. Challita, P. M., and D. B. Kohn. 1494. Lack of expression from a retroviral vector after transduction of murinc hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91:2567-2571.
6. Chang, W., C. Hubbard, C. Friedel, and H. Ruley. 1993 Enrichment of insertional mutants following retrovirus gene trap selection. Virology 193: 737-747.
7. Crystal, R. G. 1995. Transfer of genes to humans; early lessons and obstacles to success. Science 270:404-410.
8. Danos, O., and R. C. Mulligan. 1988. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85:6460-6464.
9. Donahue, R., S. Kessler, D. Bodine, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, R. Moen, J. Bacher, K. Zsebo, and A. Nienhuis. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1125-1135.
10. Dougherty, J. P., R. Wisniewski, S. Yang, B. W. Rhode, and H. M. Temin. 1989. New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J. Virol. 63:3201-3212.
11. DuBridge, R. B., P. Tang, H. C. Hsia, P.-M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
12. Emerman, M., and H. M. Temin. 1984. Gene with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39:459-467.
13. Emerman, M., and H. M. Temin. 1986. Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6:792-800.
14. Fiering, S., E. Epner, K. Robinson, Y. Zhuang, A. Telling, M. Hu, D. Martin, T. Enver, T. Ley, and M. Groudine. 1995. Targeted deletion of 5'HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Gene Dev. 9:2203-2213.
15. Grez, M., E. Akgün, F, Hiberg, and W. Ostertag. 1990. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc. Natl. Acad. Sci. USA 87:9202-9206.
16. Gu, H., Y. Zou, and K. Rajewsky. 1993. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxp-mediated gene targeting. Cell 73:1155-1164.
17. Hantzopoulos, P., B. A. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86:3519-3523.
18. Hicks, G., H. E. Ruley, and H. von Melchner. Unpublished data.
19. - vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J. Virol. 69:6839-6846.
20. Logie, C., and A. Stewart. 1995. Ligand-regulated site-specific recombination. Proc. Natl. Acad. Sci. USA 92:5940-5944.
21. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
22. Melzger. D., J. Clifford, H. Chiba, and P. Chambon. 1995. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 92:6991-6995.
23. Miller, A. D. 1992. Human gene therapy comes of age. Nature (London) 357:455-460.
24. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
25. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
26. Miyazawa, M., and R. Fujisawa. 1994. Physiology and pathology of host immune responses and endogenous murine retroviruses - from gene fragments to epitopes. Tohoku J. Exp. Med. 173:91-103.
27. Morgan, R. A., and W. F. Anderson. 1993. Human gene therapy. Annu. Rev. Biochem. 62:191-217.
28. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high tiler retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
29. Nienhuis, A. W., C. E. Walsh, and J. Liu. 1993. Viruses as therapeutic gene transfer vectors, p. 353-414. In N. S. Young (ed.). Viruses and hone marrow. Marcel Dekker. Inc., New York.
30. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
31. Reddy, S., J. V. DeGregori, H. von Melchner, and H. E. Ruley. 1991. Retrovirus promoter-trap vector to induce lacZ gene fusions in mammalian cells. J. Virol. 65:1507-1515.
32. Reddy, S., H. Rayburn, H. von Melchner, and H. E. Ruley. 1992. Fluorescence activated sorting of totipotent embryonic stem cells expressing developmentally regulated lacZ fusion genes. Proc. Natl. Acad. Sci. USA 89:6721-6725.
33. Sauer, B., and N. Henderson. 1988. Site-specific recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85:5166-5170.
34. Schmitt, R., E. Bruyns, and H. Snodgrass. 1991. Hematopoictic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes Dev. 5:728-740.
35. Smith, A. J. H., M. A. De Sousa, B. Kwabi-Addo, A. Heppel-Parton, H. Impey, and P. Rabbitts. 1995. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nature Genet. 9:376-385.
36. Stuhlmann, H., R. Jaenisch, and R. C. Mulligan. 1989. Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance. Mol. Cell. Biol. 9:100-108.
37. Temin, H. M. 1990. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum. Gene Ther. 1:111-123.
38. Valera, A., J. C. Perales, M. Hatzoglou, and F. Bosch. 1994. Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5:449-456.
39. Vanin, E., M. Kaloss, C. Broscius, and A. Nienhuis. 1994. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68:4241-4250.
40. van Lohuizen, M., and A. Berns. 1990. Tumorigenesis by slow-transforming retroviruses - an update. Biochim. Biophys. Acta 1032:213-235.
41. Varmus, H. 1988. Retroviruses. Science 240:1427-1435.
42. von Melchner, H., J. V. DeGregori, H. Rayburn, S. Reddy, C. Friedel, and H. E. Ruley. 1992. Selective disruption of genes expressed in totipotent embryonic stem cells. Genes Dev. 6:919-927.
43. von Melchner, H., and D. E. Housman. 1988. The expression of the neomycin phosphotransferase in human promyelocytic leukemia cells (HL-60) delays their differentiation. Oncogene 2:137-140.
44. von Melchner, H., S. Reddy, and H. E. Ruley. 1990. Isolation of cellular promoters by using a retrovirus promoter trap. Proc. Natl. Acad. Sci. USA 87:3733-3737.
45. von Melchner, H., and H. E. Ruley. 1989. Identification of cellular promoters by using a retrovirus promoter trap. J. Virol. 63:3227-3233.
46. von Melchner, H., and H. E. Ruley. 1995. Gene entrapment, p. 109-129. In F. Farzaneh and D. N. Cooper (ed.), Functional analysis of the human genome. Bios Scientific Publishers, Oxford.
47. Yamauchi, M., B. Freitag, C. Khan, B. Berwin, and E. Barklis. 1995. Stem cell factor binding to retrovirus primer binding site silencers. J. Virol. 69: 1142-1149.
48. Zahn, D., and H. von Melchner. Unpublished data.